Manchester’s Yourgene wins another Covid contract

Manchester-based molecular diagnostics firm Yourgene Health plc announced that Yourgene Genomic Services (YG) has been awarded a contract for the provision of laboratory capacity to support the Winter Surge Covid-19 testing by the Department of Health & Social Care (DHSC), running until March 31, 2022.

The ‘Mini Tender Winter Surge Capacity (C47365)’ contract is the third DHSC contract awarded to the group this year under the Public Health England National Microbiology Framework Agreement,” said Yourgene.

“The previous two awards include the Covid-19 PCR surge testing announced on 19 August 2021 and the recent UKHSA sequencing contract announced on 14 December 2021.”

Yourgene CEO Lyn Rees said: “This is another strong endorsement of our progress and we are pleased to be able to support the nation’s Covid testing effort.

“Actual value for this contract will depend on the services purchased, with no committed spend at this moment in time, but we look forward to updating shareholders on the progress over time.” 

About the Author

Mark McSherry
Dalriada Media LLC sites are edited by veteran news journalist Mark McSherry, a former staff editor and reporter with Reuters, Bloomberg and major newspapers including the South China Morning Post, London's Sunday Times and The Scotsman. McSherry's journalism has also appeared in The Washington Post, The Guardian, The Independent, The New York Times, London's Evening Standard and Forbes. McSherry is also a professor of journalism and communication arts in universities and colleges in New York City. Scottish-born McSherry has an MBA from the University of Edinburgh and a Certificate in Global Affairs from New York University.